Medicare Coverage of Wegovy Raises Questions Regarding the Affordability and Accessibility of Novel Medications

Last week, the Centers for Medicare & Medicaid Services (CMS) announced that it would allow health plans under Medicare Part D (the Medicare prescription drug benefit) to cover Wegovy and other weight-loss medications if they receive Food and Drug Administration (FDA) approval for an additional medically accepted indication….
By: McDermott+Consulting
Previous Story

Client Alert: The Supreme Court Signals That Access to Mifepristone Will Likely Remain Safe for Now

Next Story

More Than 70 Million Customers’ Names and Social Security Numbers Ended Up Online in Apparent AT&T Data Breach